oru.sePublikationer
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
World Health Organization, radiofrequency radiation and health: a hard nut to crack (Review)
Department of Oncology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
2017 (English)In: International journal of oncology, ISSN 1791-2423, Vol. 51, no 2, 405-413 p.Article in journal (Other academic) Published
Abstract [en]

In May 2011 the International Agency for Research on Cancer (IARC) evaluated cancer risks from radiofrequency (RF) radiation. Human epidemiological studies gave evidence of increased risk for glioma and acoustic neuroma. RF radiation was classified as Group 2B, a possible human carcinogen. Further epidemiological, animal and mechanistic studies have strengthened the association. In spite of this, in most countries little or nothing has been done to reduce exposure and educate people on health hazards from RF radiation. On the contrary ambient levels have increased. In 2014 the WHO launched a draft of a Monograph on RF fields and health for public comments. It turned out that five of the six members of the Core Group in charge of the draft are affiliated with International Commission on Non-Ionizing Radiation Protection (ICNIRP), an industry loyal NGO, and thus have a serious conflict of interest. Just as by ICNIRP, evaluation of non-thermal biological effects from RF radiation are dismissed as scientific evidence of adverse health effects in the Monograph. This has provoked many comments sent to the WHO. However, at a meeting on March 3, 2017 at the WHO Geneva office it was stated that the WHO has no intention to change the Core Group.

Place, publisher, year, edition, pages
Spandidos Publications , 2017. Vol. 51, no 2, 405-413 p.
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:oru:diva-60809DOI: 10.3892/ijo.2017.4046ISI: 000405642300002PubMedID: 28656257Scopus ID: 2-s2.0-85021790903OAI: oai:DiVA.org:oru-60809DiVA: diva2:1148357
Funder
Cancer and Allergy Foundation
Note

Funding Agencies:

Cancerhjalpen 

Available from: 2017-10-10 Created: 2017-10-10 Last updated: 2017-10-23Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMedScopus

Authority records BETA

Hardell, Lennart

Search in DiVA

By author/editor
Hardell, Lennart
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 6 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf